Friday, August 31, 2018

Drug-resistance of gonorrhea in the EU: Persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin have remained stable when compared to recent years.

from Top Health News -- ScienceDaily https://ift.tt/2PSy68j

No comments:

Post a Comment

Powerful cholesterol drug cuts heart attack risk by 31%

A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically use...